Incyte Corp. (INCY)
121.70
-0.57
(-0.47%)
USD |
NASDAQ |
Nov 12, 16:00
121.72
+0.02
(+0.02%)
After-Hours: 20:00
Incyte Price : 121.70 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 123.09 | 123.90 | 121.29 | 121.70 | 1.009M |
| Nov 11, 2026 | 119.37 | 122.73 | 117.84 | 122.27 | 1.188M |
| Nov 10, 2026 | 120.58 | 121.25 | 119.03 | 120.30 | 1.798M |
| Nov 09, 2026 | 120.59 | 122.07 | 118.26 | 121.89 | 1.155M |
| Nov 06, 2026 | 116.38 | 119.81 | 115.00 | 119.65 | 1.486M |
| Nov 05, 2026 | 123.96 | 123.96 | 117.88 | 118.01 | 1.600M |
| Nov 04, 2026 | 117.52 | 123.33 | 117.52 | 122.85 | 2.141M |
| Nov 03, 2026 | 118.96 | 121.26 | 117.26 | 117.59 | 2.172M |
| Nov 02, 2026 | 119.02 | 121.52 | 118.25 | 120.04 | 1.748M |
| Oct 30, 2026 | 120.10 | 122.87 | 119.55 | 120.39 | 2.840M |
| Oct 29, 2026 | 111.64 | 117.09 | 111.01 | 116.80 | 3.048M |
| Oct 28, 2026 | 115.50 | 118.49 | 114.74 | 116.87 | 1.808M |
| Oct 27, 2026 | 111.18 | 116.76 | 111.18 | 116.60 | 2.231M |
| Oct 26, 2026 | 115.48 | 115.92 | 112.74 | 113.31 | 2.264M |
| Oct 23, 2026 | 116.75 | 116.86 | 115.12 | 115.71 | 1.477M |
| Oct 22, 2026 | 113.93 | 117.17 | 112.76 | 116.93 | 2.236M |
| Oct 21, 2026 | 115.98 | 116.57 | 113.35 | 113.44 | 1.405M |
| Oct 20, 2026 | 113.78 | 117.00 | 113.26 | 116.62 | 1.342M |
| Oct 19, 2026 | 113.19 | 114.38 | 112.71 | 113.25 | 1.190M |
| Oct 16, 2026 | 113.98 | 114.57 | 112.02 | 113.07 | 1.581M |
| Oct 15, 2026 | 112.71 | 116.03 | 112.60 | 113.27 | 1.940M |
| Oct 14, 2026 | 108.61 | 112.06 | 107.83 | 111.57 | 1.870M |
| Oct 13, 2026 | 111.29 | 111.68 | 107.78 | 108.62 | 2.590M |
| Oct 12, 2026 | 114.05 | 114.05 | 111.26 | 111.36 | 1.479M |
| Oct 09, 2026 | 112.35 | 113.87 | 111.80 | 112.79 | 1.122M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 951.19 |
| Mirum Pharmaceuticals, Inc. | 93.33 |
| AbbVie, Inc. | 294.45 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Biogen, Inc. | 250.48 |
Price Related Metrics
| PE Ratio | 64.76 |
| PS Ratio | 4.166 |
| Price to Book Value | 4.400 |
| Price to Free Cash Flow | 36.83 |
| Earnings Yield | 1.54% |
| Market Cap | 24.83B |
| Operating PE Ratio | 35.72 |
| Normalized PE Ratio | 57.32 |